Oct 9 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback